The Department of Health (DH) has launched the Fleming Fund, a £265 million One Health programme to support low and middle income countries (LMICs) in tackling antimicrobial resistance (AMR).
To deliver the Fleming Fund, DH has contracted Itad to deliver an independent evaluation of the Fleming Fund country and regional level projects.
AMR is a global problem that needs concerted action at both a national and global level using a “One Health” approach that spans work across the human, veterinary, agriculture, environment and development sectors. The UK is at the forefront of action to address the threat of AMR, building on the commitment made by all countries in adopting a Global Action Plan on AMR at the World Health Assembly in 2015.
Drug-resistant infections could kill an extra 10 million people across the world every year by 2050 if they are not tackled. By this date they could also cost the world around $100 trillion in lost output: more than the size of the current world economy (Review on Antimicrobial Resistance, 2014).
Ongoing systematic collection, analysis, and interpretation of data is essential to the planning, implementation and evaluation of antimicrobial practice, closely integrated with the dissemination of these data to those who need to know and linked to prevention and control.
The Fleming Fund will improve laboratory capacity and capability for diagnostics as well as data and surveillance of AMR in low and middle income countries (LMICs).